Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 14/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.68 |
| ▸ | MEN1 | O00255 | 8/20 | 0.68 |
| ▸ | RAB9A | P51151 | 2/20 | 0.68 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.63 |
| ▸ | HTT | P42858 | 5/20 | 0.63 |
| ▸ | LMNA | P02545 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 5/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15836672 | 0.86 | ALDH1A1 (0.74) | MAPTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL15836649 | 0.82 | ALDH1A1 (0.70) | MAPTALDH1A1KMT2AMEN1GPR55 | |
| SCHEMBL15836652 | 0.82 | KMT2A (0.72) | MAPTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL15836660 | 0.78 | MAPT (0.70) | MAPTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL13454566 | 0.76 | MAPT (1.00) | MAPTALDH1A1KMT2AMEN1GPR55 | |
| SCHEMBL15836658 | 0.75 | SMN1; SMN2 (0.73) | MAPTALDH1A1KMT2AMEN1GPR55 | |
| SCHEMBL14096400 | 0.75 | MAPT (0.65) | MAPTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL15840658 | 0.73 | KMT2A (0.75) | MAPTALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL15836648 | 0.73 | ALDH1A1 (1.00) | MAPTALDH1A1KMT2AMEN1GPR55 | |
| SCHEMBL15840526 | 0.73 | KMT2A (1.00) | MAPTALDH1A1KMT2AMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | Errico, Joseph P. (US) | 2014-06-26 | — | — | US | disclosed |
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | Errico, Joseph P. (US) | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | EGFR, ERBB2, ERBB3 | MAPT 1076/4885ALDH1A1 4348/4885KMT2A 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.